309 related articles for article (PubMed ID: 28484084)
1. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Li O; Yi W; Yang P; Guo C; Peng C
Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
[TBL] [Abstract][Full Text] [Related]
7. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
[TBL] [Abstract][Full Text] [Related]
8. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
[TBL] [Abstract][Full Text] [Related]
9. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.
Kato Y; Takahashi S; Gotohda N; Konishi M
J Gastrointest Surg; 2016 Aug; 20(8):1435-43. PubMed ID: 27250990
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
[TBL] [Abstract][Full Text] [Related]
13. Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.
Hu HJ; Jin YW; Zhou RX; Ma WJ; Yang Q; Wang JK; Liu F; Cheng NS; Li FY
J Gastrointest Surg; 2019 Mar; 23(3):510-517. PubMed ID: 30076591
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
15. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma.
Ding G; Yang Y; Cao L; Chen W; Wu Z; Jiang G
World J Surg Oncol; 2015 Mar; 13():99. PubMed ID: 25889726
[TBL] [Abstract][Full Text] [Related]
16. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
Yan Y; Lu N; Tian W; Liu T
Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
[TBL] [Abstract][Full Text] [Related]
17. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma.
Ye XW; Hu HJ; Xiong XZ; Lu J; Cheng NS
Surg Today; 2021 Aug; 51(8):1352-1360. PubMed ID: 33651221
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
[TBL] [Abstract][Full Text] [Related]
19. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.
Zhang XF; Beal EW; Merath K; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
J Surg Oncol; 2018 May; 117(6):1267-1277. PubMed ID: 29205351
[TBL] [Abstract][Full Text] [Related]
20. Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.
Li C; Li X; Wu L; Jiang Z
Technol Cancer Res Treat; 2017 Aug; 16(4):421-427. PubMed ID: 27143047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]